Montelukast Impurity 11 | CAS 855473-50-6 - Request Quote
Montelukast Impurity 11
| SZ CAT No: | SZ-M031084 |
| CAS No | 855473-50-6 |
| Mol.F. | C7H11BrO2 |
| Mol.Wt. | 207.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Montelukast Impurity 11 is chemically Methyl 2-(1-(bromomethyl)cyclopropyl)acetate. Montelukast Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Montelukast Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Montelukast.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 855473-50-6
Purchase 855473-50-6
Order 855473-50-6
Enquire 855473-50-6
price of 855473-50-6
855473-50-6 Supplier
855473-50-6 Manufacturer
855473-50-6 Exporter
buy high quality Montelukast Impurity 11
Purchase Montelukast Impurity 11
Montelukast Impurity 11 suppliers
Montelukast Impurity 11 manufacturers
Montelukast Impurity 11 price
Order Montelukast Impurity 11
Enquire Montelukast Impurity 11
Montelukast Impurity 11 cost
Montelukast Impurity 11 Supplier
Montelukast Impurity 11 Distributor
Montelukast Impurity 11 for Method Validation
Montelukast Reference Standard
Montelukast Impurity 11 for ANDA Filing
Montelukast Impurity 11 for Forced Degradation Studies
Montelukast Impurity 11 Identification Standards
Montelukast Impurity 11 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


